<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Mol Biol Lett</journal-id><journal-id journal-id-type="iso-abbrev">Cell. Mol. Biol. Lett</journal-id><journal-title-group><journal-title>Cellular &#x00026; Molecular Biology Letters</journal-title></journal-title-group><issn pub-type="ppub">1425-8153</issn><issn pub-type="epub">1689-1392</issn><publisher><publisher-name>SP Versita</publisher-name><publisher-loc>Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20336406</article-id><article-id pub-id-type="pmc">6275920</article-id><article-id pub-id-type="publisher-id">9</article-id><article-id pub-id-type="doi">10.2478/s11658-010-0009-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The anti-apoptotic protein lifeguard is expressed in breast cancer cells and tissues</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Bucan</surname><given-names>Vesna</given-names></name><address><phone>0511-532-8856</phone><fax>0511-532-8890</fax><email>Bucan.vesna@mh-hannover.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Reimers</surname><given-names>Kerstin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Claudia Yu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Eddy</surname><given-names>Mau-Thek</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Vogt</surname><given-names>Peter M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.10423.34</institution-id><institution-id institution-id-type="ISNI">0000000095299877</institution-id><institution>Department of Plastic, Hand and Reconstructive Surgery, </institution><institution>Medical School of Hannover, </institution></institution-wrap>Podbielskistra&#x000df;e 380, D-30659 Hannover, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.10423.34</institution-id><institution-id institution-id-type="ISNI">0000000095299877</institution-id><institution>Abteilung f&#x000fc;r Plastische, Hand- und Wiederherstellungschirurgie, </institution><institution>Medizinische Hochschule Hannover, </institution></institution-wrap>Carl-Neubergstr. 1, 30625 Hannover, Germany </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>3</month><year>2010</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2010</year></pub-date><volume>15</volume><issue>2</issue><fpage>296</fpage><lpage>310</lpage><history><date date-type="received"><day>7</day><month>10</month><year>2009</year></date><date date-type="accepted"><day>4</day><month>3</month><year>2010</year></date></history><permissions><copyright-statement>&#x000a9; &#x000a9; Versita Warsaw and Springer-Verlag Wien 2010</copyright-statement></permissions><abstract id="Abs1"><p>Lifeguard (LFG) is an anti-apoptotic protein that inhibits Fas-mediated death in tumour cells. However, the molecular function of human LFG in the carcinogenesis of human breast cells is uncertain. We studied the expression and function of endogenous LFG in four breast cancer cell lines (MCF-7, MDA-MB-231, T-47D and HS 578T), a human breast epithelial cell line (HS 578Bst), and in healthy and cancerous breast tissues. Molecular (Western blot and RT-PCR) and immunohistochemical techniques were used to investigate the LFG expression. To investigate the breast cancer cell proliferation in the presence of Fas, we performed fluorescent cell viability assays. The possible association of Fas with LFG was analyzed by immunofluorescence microscopy. In this paper, we provide convincing evidence that LFG is overexpressed in several human breast cancer cell lines. More importantly, we found that the LFG expression correlates with high tumour grades in primary breast tumours. Finally, we demonstrated that Fas sensitivity is reduced in breast cancer cell lines expressing LFG. Our results indicated that LFG is strongly expressed in breast cancer epithelial cells. Moreover, the overexpression of LFG correlated with tumour grade and reduced Fas sensitivity. Our findings support the idea that LFG may have a role in the downregulation of apoptosis in breast cancer cells.</p></abstract><kwd-group xml:lang="en"><title>Key words</title><kwd>Apoptosis</kwd><kwd>Lifeguard</kwd><kwd>Fas</kwd><kwd>Breast cancer</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; &#x000a9; Versita Warsaw and Springer-Verlag Wien 2010</meta-value></custom-meta></custom-meta-group></article-meta></front><back><glossary><title>Abbreviations used</title><def-list><def-item><term>BI-1</term><def><p>Bax inhibitor-1</p></def></def-item><def-item><term>DAPI</term><def><p>4&#x02019;, 6&#x02019;-diamidino-2-phenylindole</p></def></def-item><def-item><term>EDTA</term><def><p>ethylenediaminetetraacetic acid</p></def></def-item><def-item><term>EGF</term><def><p>epidermal growth factor</p></def></def-item><def-item><term>FCS</term><def><p>fetal calf serum</p></def></def-item><def-item><term>LFG</term><def><p>Lifeguard</p></def></def-item><def-item><term>RT-PCR</term><def><p>reverse transcribed polymerase chain reaction</p></def></def-item><def-item><term>PMSF</term><def><p>phenylmethyl sulfonyl fluoride</p></def></def-item><def-item><term>PVDF</term><def><p>polyvinylidene fluoride</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>J.C.</given-names></name></person-group><article-title>Mechanisms of apoptosis</article-title><source>Am. J. Pathol.</source><year>2000</year><volume>157</volume><fpage>1415</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">11073801</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjostrom</surname><given-names>J.</given-names></name><name><surname>Bergh</surname><given-names>J.</given-names></name></person-group><article-title>How apoptosis is regulated, and what goes wrong in cancer</article-title><source>BMJ</source><year>2001</year><volume>322</volume><fpage>1538</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1136/bmj.322.7301.1538</pub-id><pub-id pub-id-type="pmid">11420280</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boise</surname><given-names>L.H.</given-names></name><name><surname>Gonzalez-Garcia</surname><given-names>M.</given-names></name><name><surname>Postema</surname><given-names>C.E.</given-names></name><name><surname>Ding</surname><given-names>L.</given-names></name><name><surname>Lindsten</surname><given-names>T.</given-names></name><name><surname>Turka</surname><given-names>L.A.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>Nunez</surname><given-names>G.</given-names></name><name><surname>Thompson</surname><given-names>C.B.</given-names></name></person-group><article-title>Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death</article-title><source>Cell</source><year>1993</year><volume>74</volume><fpage>597</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90508-N</pub-id><pub-id pub-id-type="pmid">8358789</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>J.M.</given-names></name><name><surname>Gallo</surname><given-names>G.J.</given-names></name><name><surname>Elangovan</surname><given-names>B.</given-names></name><name><surname>Houghton</surname><given-names>A.B.</given-names></name><name><surname>Malstrom</surname><given-names>S.</given-names></name><name><surname>Avery</surname><given-names>B.J.</given-names></name><name><surname>Ebb</surname><given-names>R.G.</given-names></name><name><surname>Subramanian</surname><given-names>T.</given-names></name><name><surname>Chittenden</surname><given-names>T.</given-names></name><name><surname>Lutz</surname><given-names>R.J.</given-names></name></person-group><article-title>Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins</article-title><source>Oncogene</source><year>1995</year><volume>11</volume><fpage>1921</fpage><lpage>1928</lpage><pub-id pub-id-type="pmid">7478623</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oltvai</surname><given-names>Z.N.</given-names></name><name><surname>Milliman</surname><given-names>C.L.</given-names></name><name><surname>Korsmeyer</surname><given-names>S.J.</given-names></name></person-group><article-title>Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death</article-title><source>Cell</source><year>1993</year><volume>74</volume><fpage>609</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90509-O</pub-id><pub-id pub-id-type="pmid">8358790</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>E.</given-names></name><name><surname>Zha</surname><given-names>J.</given-names></name><name><surname>Jockel</surname><given-names>J.</given-names></name><name><surname>Boise</surname><given-names>L.H.</given-names></name><name><surname>Thompson</surname><given-names>C.B.</given-names></name><name><surname>Korsmeyer</surname><given-names>S.J.</given-names></name></person-group><article-title>Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death</article-title><source>Cell</source><year>1995</year><volume>80</volume><fpage>285</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90411-5</pub-id><pub-id pub-id-type="pmid">7834748</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Certo</surname><given-names>M.</given-names></name><name><surname>Del</surname><given-names>G.M.</given-names></name><name><surname>Nishino</surname><given-names>M.</given-names></name><name><surname>We</surname><given-names>I.G.</given-names></name><name><surname>Korsmeyer</surname><given-names>S.</given-names></name><name><surname>Armstrong</surname><given-names>S.A.</given-names></name><name><surname>Letai</surname><given-names>A.</given-names></name></person-group><article-title>Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members</article-title><source>Cancer Cell</source><year>2006</year><volume>9</volume><fpage>351</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2006.03.027</pub-id><pub-id pub-id-type="pmid">16697956</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uren</surname><given-names>R.T.</given-names></name><name><surname>Dewson</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Coyne</surname><given-names>S.C.</given-names></name><name><surname>Huang</surname><given-names>D.C.</given-names></name><name><surname>Adams</surname><given-names>J.M.</given-names></name><name><surname>Kluck</surname><given-names>R.M.</given-names></name></person-group><article-title>Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak</article-title><source>J. Cell. Biol.</source><year>2007</year><volume>177</volume><fpage>277</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1083/jcb.200606065</pub-id><pub-id pub-id-type="pmid">17452531</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>S.N.</given-names></name><name><surname>Fletcher</surname><given-names>J.I.</given-names></name><name><surname>Kaufmann</surname><given-names>T.</given-names></name><name><surname>van Delft</surname><given-names>M.F.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Czabotar</surname><given-names>P.E.</given-names></name><name><surname>Ierino</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>E.F.</given-names></name><name><surname>Fairlie</surname><given-names>W.D.</given-names></name><name><surname>Bouillet</surname><given-names>P.</given-names></name><name><surname>Strasser</surname><given-names>A.</given-names></name><name><surname>Kluck</surname><given-names>R.N.</given-names></name><name><surname>Adams</surname><given-names>S.M.</given-names></name><name><surname>Huang</surname><given-names>D.C.</given-names></name></person-group><article-title>Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>856</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1126/science.1133289</pub-id><pub-id pub-id-type="pmid">17289999</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yethon</surname><given-names>J.A.</given-names></name><name><surname>Epand</surname><given-names>R.F.</given-names></name><name><surname>Leber</surname><given-names>B.</given-names></name><name><surname>Epand</surname><given-names>R.M.</given-names></name><name><surname>Andrews</surname><given-names>D.W.</given-names></name></person-group><article-title>Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>48935</fpage><lpage>48941</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306289200</pub-id><pub-id pub-id-type="pmid">14522999</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chipuk</surname><given-names>J.E.</given-names></name><name><surname>Kuwana</surname><given-names>T.</given-names></name><name><surname>Bouchier-Hayes</surname><given-names>L.</given-names></name><name><surname>Droin</surname><given-names>N.M.</given-names></name><name><surname>Newmeyer</surname><given-names>D.D.</given-names></name><name><surname>Schuler</surname><given-names>M.</given-names></name><name><surname>Green</surname><given-names>D.R.</given-names></name></person-group><article-title>Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>1010</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1126/science.1092734</pub-id><pub-id pub-id-type="pmid">14963330</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orrenius</surname><given-names>S.</given-names></name></person-group><article-title>Apoptosis: molecular mechanisms and implications for human disease</article-title><source>J. Intern. Med.</source><year>1995</year><volume>237</volume><fpage>529</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.1995.tb00881.x</pub-id><pub-id pub-id-type="pmid">7782723</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>C.B.</given-names></name></person-group><article-title>Apoptosis in the pathogenesis and treatment of disease</article-title><source>Science</source><year>1995</year><volume>267</volume><fpage>1456</fpage><lpage>1462</lpage><pub-id pub-id-type="doi">10.1126/science.7878464</pub-id><pub-id pub-id-type="pmid">7878464</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>J.C.</given-names></name><name><surname>Pellecchia</surname><given-names>M.</given-names></name></person-group><article-title>Apoptosis-based therapies for hematologic malignancies</article-title><source>Blood</source><year>2005</year><volume>106</volume><fpage>408</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-07-2761</pub-id><pub-id pub-id-type="pmid">15797997</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oltersdorf</surname><given-names>T.</given-names></name><name><surname>Elmore</surname><given-names>S.W.</given-names></name><name><surname>Shoemaker</surname><given-names>A.R.</given-names></name><name><surname>Armstrong</surname><given-names>R.C.</given-names></name><name><surname>Augeri</surname><given-names>D.J.</given-names></name><name><surname>Belli</surname><given-names>B.A.</given-names></name><name><surname>Bruncko</surname><given-names>M.</given-names></name><name><surname>Deckwerth</surname><given-names>T.L.</given-names></name><name><surname>Dinges</surname><given-names>J.</given-names></name><name><surname>Hajduk</surname><given-names>P.J.</given-names></name><name><surname>Joseph</surname><given-names>M.K.</given-names></name><name><surname>Kitada</surname><given-names>S.</given-names></name><name><surname>Korsmeyer</surname><given-names>S.J.</given-names></name><name><surname>Kunzer</surname><given-names>A.R.</given-names></name><name><surname>Letai</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Mitten</surname><given-names>M.J.</given-names></name><name><surname>Nettesheim</surname><given-names>D.G.</given-names></name><name><surname>Ng</surname><given-names>S.</given-names></name><name><surname>Nimmer</surname><given-names>P.M.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>J.M.</given-names></name><name><surname>Oleksijew</surname><given-names>A.</given-names></name><name><surname>Petros</surname><given-names>A.M.</given-names></name><name><surname>Reed</surname><given-names>J.C.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Tahir</surname><given-names>S.K.</given-names></name><name><surname>Thompson</surname><given-names>C.B.</given-names></name><name><surname>Tomaselli</surname><given-names>K.J.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Wendt</surname><given-names>M.D.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Fesik</surname><given-names>S.W.</given-names></name><name><surname>Rosenberg</surname><given-names>S.H.</given-names></name></person-group><article-title>An inhibitor of Bcl-2 family proteins induces regression of solid tumours</article-title><source>Nature</source><year>2005</year><volume>435</volume><fpage>677</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1038/nature03579</pub-id><pub-id pub-id-type="pmid">15902208</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldar</surname><given-names>S.</given-names></name><name><surname>Negrini</surname><given-names>M.</given-names></name><name><surname>Monne</surname><given-names>M.</given-names></name><name><surname>Sabbioni</surname><given-names>S.</given-names></name><name><surname>Croce</surname><given-names>C.M.</given-names></name></person-group><article-title>Down-regulation of bcl-2 by p53 in breast cancer cells</article-title><source>Cancer Res.</source><year>1994</year><volume>54</volume><fpage>2095</fpage><lpage>2097</lpage><pub-id pub-id-type="pmid">8174112</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollstein</surname><given-names>M.</given-names></name><name><surname>Sidransky</surname><given-names>D.</given-names></name><name><surname>Vogelstein</surname><given-names>B.</given-names></name><name><surname>Harris</surname><given-names>C.C.</given-names></name></person-group><article-title>p53 mutations in human cancers</article-title><source>Science</source><year>1991</year><volume>253</volume><fpage>49</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1126/science.1905840</pub-id><pub-id pub-id-type="pmid">1905840</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegaki</surname><given-names>N.</given-names></name><name><surname>Katsumata</surname><given-names>M.</given-names></name><name><surname>Minna</surname><given-names>J.</given-names></name><name><surname>Tsujimoto</surname><given-names>Y.</given-names></name></person-group><article-title>Expression of bcl-2 in small cell lung carcinoma cells</article-title><source>Cancer Res.</source><year>1994</year><volume>54</volume><fpage>6</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8261463</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>X.H.</given-names></name><name><surname>Mungal</surname><given-names>S.</given-names></name><name><surname>Ayscue</surname><given-names>A.</given-names></name><name><surname>Meissner</surname><given-names>J.D.</given-names></name><name><surname>Wodnicki</surname><given-names>P.</given-names></name><name><surname>Hockenbery</surname><given-names>D.</given-names></name><name><surname>Lockett</surname><given-names>S.</given-names></name><name><surname>Herman</surname><given-names>B.</given-names></name></person-group><article-title>Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53</article-title><source>J. Cell Biochem.</source><year>1995</year><volume>57</volume><fpage>509</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1002/jcb.240570316</pub-id><pub-id pub-id-type="pmid">7768985</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonnell</surname><given-names>T.J.</given-names></name><name><surname>Troncoso</surname><given-names>P.</given-names></name><name><surname>Brisbay</surname><given-names>S.M.</given-names></name><name><surname>Logothetis</surname><given-names>C.</given-names></name><name><surname>Chung</surname><given-names>L.W.</given-names></name><name><surname>Hsieh</surname><given-names>J.T.</given-names></name><name><surname>Tu</surname><given-names>S.M.</given-names></name><name><surname>Campbell</surname><given-names>M.L.</given-names></name></person-group><article-title>Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer</article-title><source>Cancer Res.</source><year>1992</year><volume>52</volume><fpage>6940</fpage><lpage>6944</lpage><pub-id pub-id-type="pmid">1458483</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Yoshimura</surname><given-names>G.</given-names></name><name><surname>Suzuma</surname><given-names>T.</given-names></name><name><surname>Umemura</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Mori</surname><given-names>I.</given-names></name><name><surname>Kakudo</surname><given-names>K.</given-names></name></person-group><article-title>Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy</article-title><source>Oncol. Rep.</source><year>2003</year><volume>10</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">12469156</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q.F.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Yoshimura</surname><given-names>G.</given-names></name><name><surname>Shan</surname><given-names>L.</given-names></name><name><surname>Suzuma</surname><given-names>T.</given-names></name><name><surname>Tamaki</surname><given-names>T.</given-names></name><name><surname>Umemura</surname><given-names>T.</given-names></name><name><surname>Kokawa</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Utsunomiya</surname><given-names>H.</given-names></name><name><surname>Mori</surname><given-names>I.</given-names></name><name><surname>Kakudo</surname><given-names>K.</given-names></name></person-group><article-title>Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma</article-title><source>Breast Cancer Res. Treat.</source><year>2000</year><volume>61</volume><fpage>211</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1023/A:1006474307180</pub-id><pub-id pub-id-type="pmid">10965997</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>M.</given-names></name><name><surname>Segura</surname><given-names>M.F.</given-names></name><name><surname>Sole</surname><given-names>C.</given-names></name><name><surname>Colino</surname><given-names>A.</given-names></name><name><surname>Comella</surname><given-names>J.X.</given-names></name><name><surname>Cena</surname><given-names>V.</given-names></name></person-group><article-title>Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment</article-title><source>J. Neurochem.</source><year>2007</year><volume>103</volume><fpage>190</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">17635665</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somia</surname><given-names>N.V.</given-names></name><name><surname>Schmitt</surname><given-names>M.J.</given-names></name><name><surname>Vetter</surname><given-names>D.E.</given-names></name><name><surname>Van Antwerp</surname><given-names>D.</given-names></name><name><surname>Heinemann</surname><given-names>S.F.</given-names></name><name><surname>Verma</surname><given-names>I.M.</given-names></name></person-group><article-title>LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>12667</fpage><lpage>12672</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.22.12667</pub-id><pub-id pub-id-type="pmid">10535980</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>J.C.</given-names></name><name><surname>Oakes</surname><given-names>S.M.</given-names></name><name><surname>Joyce-Brady</surname><given-names>M.</given-names></name></person-group><article-title>The Bax inhibitor-1 gene is differentially regulated in adult testis and developing lung by two alternative TATA-less promoters</article-title><source>Genomics</source><year>1999</year><volume>57</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1006/geno.1999.5761</pub-id><pub-id pub-id-type="pmid">10198159</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Reed</surname><given-names>J.C.</given-names></name></person-group><article-title>Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast</article-title><source>Mol. Cell</source><year>1998</year><volume>1</volume><fpage>337</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)80034-9</pub-id><pub-id pub-id-type="pmid">9660918</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimers</surname><given-names>K.</given-names></name><name><surname>Choi</surname><given-names>C.Y.</given-names></name><name><surname>Mau-Thek</surname><given-names>E.</given-names></name><name><surname>Vogt</surname><given-names>P.M.</given-names></name></person-group><article-title>Sequence analysis shows that Lifeguard belongs to a new evolutionarily conserved cytoprotective family</article-title><source>Int. J. Mol. Med.</source><year>2006</year><volume>18</volume><fpage>729</fpage><lpage>734</lpage><pub-id pub-id-type="pmid">16964429</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweitzer</surname><given-names>B.</given-names></name><name><surname>Taylor</surname><given-names>V.</given-names></name><name><surname>Welcher</surname><given-names>A.A.</given-names></name><name><surname>McClelland</surname><given-names>M.</given-names></name><name><surname>Suter</surname><given-names>U.</given-names></name></person-group><article-title>Neural membrane protein 35 (NMP35): a novel member of a gene family which is highly expressed in the adult nervous system</article-title><source>Mol. Cell Neurosci.</source><year>1998</year><volume>11</volume><fpage>260</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1006/mcne.1998.0697</pub-id><pub-id pub-id-type="pmid">9698393</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweitzer</surname><given-names>B.</given-names></name><name><surname>Suter</surname><given-names>U.</given-names></name><name><surname>Taylor</surname><given-names>V.</given-names></name></person-group><article-title>Neural membrane protein 35/Lifeguard is localized at postsynaptic sites and in dendrites</article-title><source>Brain Res. Mol. Brain Res.</source><year>2002</year><volume>107</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/S0169-328X(02)00445-X</pub-id><pub-id pub-id-type="pmid">12414123</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plati</surname><given-names>J.</given-names></name><name><surname>Bucur</surname><given-names>O.</given-names></name><name><surname>Khosravi-Far</surname><given-names>R.</given-names></name></person-group><article-title>Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities</article-title><source>J. Cell Biochem.</source><year>2008</year><volume>104</volume><fpage>1124</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1002/jcb.21707</pub-id><pub-id pub-id-type="pmid">18459149</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melet</surname><given-names>A.</given-names></name><name><surname>Song</surname><given-names>K.</given-names></name><name><surname>Bucur</surname><given-names>O.</given-names></name><name><surname>Jagani</surname><given-names>Z.</given-names></name><name><surname>Grassian</surname><given-names>A.R.</given-names></name><name><surname>Khosravi-Far</surname><given-names>R.</given-names></name></person-group><article-title>Apoptotic pathways in tumor progression and therapy</article-title><source>Adv. Exp. Med. Biol.</source><year>2008</year><volume>615</volume><fpage>47</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1007/978-1-4020-6554-5_4</pub-id><pub-id pub-id-type="pmid">18437891</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturm</surname><given-names>I.</given-names></name><name><surname>Papadopoulos</surname><given-names>S.</given-names></name><name><surname>Hillebrand</surname><given-names>T.</given-names></name><name><surname>Benter</surname><given-names>T.</given-names></name><name><surname>Luck</surname><given-names>H.J.</given-names></name><name><surname>Wolff</surname><given-names>G.</given-names></name><name><surname>D&#x000f6;rken</surname><given-names>B.</given-names></name><name><surname>Daniel</surname><given-names>P.T.</given-names></name></person-group><article-title>Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 gene</article-title><source>Int. J. Cancer</source><year>2000</year><volume>87</volume><fpage>517</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1002/1097-0215(20000815)87:4&#x0003c;517::AID-IJC9&#x0003e;3.0.CO;2-B</pub-id><pub-id pub-id-type="pmid">10918191</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soufla</surname><given-names>G.</given-names></name><name><surname>Baritaki</surname><given-names>S.</given-names></name><name><surname>Sifakis</surname><given-names>S.</given-names></name><name><surname>Zafiropoulos</surname><given-names>A.</given-names></name><name><surname>Spandidos</surname><given-names>D.A.</given-names></name></person-group><article-title>Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix</article-title><source>Int. J. Biol. Markers</source><year>2005</year><volume>20</volume><fpage>18</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">15832769</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bargou</surname><given-names>R.C.</given-names></name><name><surname>Daniel</surname><given-names>P.T.</given-names></name><name><surname>Mapara</surname><given-names>M.Y.</given-names></name><name><surname>Bommert</surname><given-names>K.</given-names></name><name><surname>Wagener</surname><given-names>C.</given-names></name><name><surname>Kallinich</surname><given-names>B.</given-names></name><name><surname>Royer</surname><given-names>H.D.</given-names></name><name><surname>D&#x000f6;rken</surname><given-names>B.</given-names></name></person-group><article-title>Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis</article-title><source>Int. J. Cancer</source><year>1995</year><volume>60</volume><fpage>854</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1002/ijc.2910600622</pub-id><pub-id pub-id-type="pmid">7896458</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldar</surname><given-names>S.</given-names></name><name><surname>Negrini</surname><given-names>M.</given-names></name><name><surname>Monne</surname><given-names>M.</given-names></name><name><surname>Sabbioni</surname><given-names>S.</given-names></name><name><surname>Croce</surname><given-names>C.M.</given-names></name></person-group><article-title>Down-regulation of bcl-2 by p53 in breast cancer cells</article-title><source>Cancer Res.</source><year>1994</year><volume>54</volume><fpage>2095</fpage><lpage>2097</lpage><pub-id pub-id-type="pmid">8174112</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname><given-names>R.D.</given-names></name><name><surname>Kaklamanis</surname><given-names>L.</given-names></name><name><surname>Pezzella</surname><given-names>F.</given-names></name><name><surname>Gatter</surname><given-names>K.C.</given-names></name><name><surname>Harris</surname><given-names>A.L.</given-names></name></person-group><article-title>Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer</article-title><source>Br. J. Cancer</source><year>1994</year><volume>69</volume><fpage>135</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">8286195</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>A.M.</given-names></name><name><surname>Pfannenschmidt</surname><given-names>S.</given-names></name><name><surname>Tscheslog</surname><given-names>H.</given-names></name><name><surname>Maass</surname><given-names>N.</given-names></name><name><surname>Rosel</surname><given-names>F.</given-names></name><name><surname>Mehdorn</surname><given-names>H.M.</given-names></name><name><surname>Held-Feindt</surname><given-names>J.</given-names></name></person-group><article-title>Reduced mRNA and protein expression of BCL-2 versus decreased mRNA and increased protein expression of BAX in breast cancer brain metastases: a real-time PCR and immunohistochemical evaluation</article-title><source>Neurol. Res.</source><year>2006</year><volume>28</volume><fpage>787</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1179/016164106X110364</pub-id><pub-id pub-id-type="pmid">17288732</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajewski</surname><given-names>S.</given-names></name><name><surname>Blomqvist</surname><given-names>C.</given-names></name><name><surname>Franssila</surname><given-names>K.</given-names></name><name><surname>Krajewska</surname><given-names>M.</given-names></name><name><surname>Wasenius</surname><given-names>V.M.</given-names></name><name><surname>Niskanen</surname><given-names>E.</given-names></name><name><surname>Nordling</surname><given-names>S.</given-names></name><name><surname>Reed</surname><given-names>J.C.</given-names></name></person-group><article-title>Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma</article-title><source>Cancer Res.</source><year>1995</year><volume>55</volume><fpage>4471</fpage><lpage>4478</lpage><pub-id pub-id-type="pmid">7671262</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grzmil</surname><given-names>M.</given-names></name><name><surname>Thelen</surname><given-names>P.</given-names></name><name><surname>Hemmerlein</surname><given-names>B.</given-names></name><name><surname>Schweyer</surname><given-names>S.</given-names></name><name><surname>Voigt</surname><given-names>S.</given-names></name><name><surname>Mury</surname><given-names>D.</given-names></name><name><surname>Burfeind</surname><given-names>P.</given-names></name></person-group><article-title>Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells</article-title><source>Am. J. Pathol.</source><year>2003</year><volume>163</volume><fpage>543</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">12875974</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grzmil</surname><given-names>M.</given-names></name><name><surname>Kaulfuss</surname><given-names>S.</given-names></name><name><surname>Thelen</surname><given-names>P.</given-names></name><name><surname>Hemmerlein</surname><given-names>B.</given-names></name><name><surname>Schweyer</surname><given-names>S.</given-names></name><name><surname>Obenauer</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>T.W.</given-names></name><name><surname>Burfeind</surname><given-names>P.</given-names></name></person-group><article-title>Expression and functional analysis of Bax inhibitor-1 in human breast cancer cells</article-title><source>J. Pathol.</source><year>2006</year><volume>208</volume><fpage>340</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1002/path.1902</pub-id><pub-id pub-id-type="pmid">16353131</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>R.</given-names></name><name><surname>Ishiyama</surname><given-names>T.</given-names></name><name><surname>Uchihara</surname><given-names>T.</given-names></name><name><surname>Inadome</surname><given-names>Y.</given-names></name><name><surname>Iijima</surname><given-names>T.</given-names></name><name><surname>Morishita</surname><given-names>Y.</given-names></name><name><surname>Kano</surname><given-names>J.</given-names></name><name><surname>Goya</surname><given-names>T.</given-names></name><name><surname>Noguchi</surname><given-names>M.</given-names></name></person-group><article-title>Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma</article-title><source>Cancer</source><year>2006</year><volume>106</volume><fpage>648</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1002/cncr.21639</pub-id><pub-id pub-id-type="pmid">16353209</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villalva</surname><given-names>C.</given-names></name><name><surname>Trempat</surname><given-names>P.</given-names></name><name><surname>Greenland</surname><given-names>C.</given-names></name><name><surname>Thomas</surname><given-names>C.</given-names></name><name><surname>Girard</surname><given-names>J.P.</given-names></name><name><surname>Moebius</surname><given-names>F.</given-names></name><name><surname>Delsol</surname><given-names>G.</given-names></name><name><surname>Brousset</surname><given-names>P.</given-names></name></person-group><article-title>Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma</article-title><source>Br. J. Haematol.</source><year>2002</year><volume>188</volume><fpage>791</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2141.2002.03671.x</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimers</surname><given-names>K.</given-names></name><name><surname>Choi</surname><given-names>C.Y.</given-names></name><name><surname>Bucan</surname><given-names>V.</given-names></name><name><surname>Vogt</surname><given-names>P.M.</given-names></name></person-group><article-title>The Bax Inhibitor-1 (BI-1) family in apoptosis and tumorigenesis</article-title><source>Curr. Mol. Med.</source><year>2008</year><volume>8</volume><fpage>148</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.2174/156652408783769562</pub-id><pub-id pub-id-type="pmid">18336295</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esseghir</surname><given-names>S.</given-names></name><name><surname>Reis-Filho</surname><given-names>J.S.</given-names></name><name><surname>Kennedy</surname><given-names>A.</given-names></name><name><surname>James</surname><given-names>M.</given-names></name><name><surname>O&#x02019;Hare</surname><given-names>M.J.</given-names></name><name><surname>Jeffery</surname><given-names>R.</given-names></name><name><surname>Poulsom</surname><given-names>R.</given-names></name><name><surname>Isacke</surname><given-names>C.M.</given-names></name></person-group><article-title>Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts</article-title><source>J. Pathol.</source><year>2006</year><volume>210</volume><fpage>420</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1002/path.2071</pub-id><pub-id pub-id-type="pmid">17054309</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>S.</given-names></name><name><surname>Golstein</surname><given-names>P.</given-names></name></person-group><article-title>The Fas death factor</article-title><source>Science</source><year>1995</year><volume>267</volume><fpage>1449</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.1126/science.7533326</pub-id><pub-id pub-id-type="pmid">7533326</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hengartner</surname><given-names>M.O.</given-names></name></person-group><article-title>The biochemistry of apoptosis</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>770</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1038/35037710</pub-id><pub-id pub-id-type="pmid">11048727</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landowski</surname><given-names>T.H.</given-names></name><name><surname>Gleason-Guzman</surname><given-names>M.C.</given-names></name><name><surname>Dalton</surname><given-names>W.S.</given-names></name></person-group><article-title>Selection for drug resistance results in resistance to Fas-mediated apoptosis</article-title><source>Blood</source><year>1997</year><volume>89</volume><fpage>1854</fpage><lpage>1861</lpage><pub-id pub-id-type="pmid">9058704</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toillon</surname><given-names>R.A.</given-names></name><name><surname>Descamps</surname><given-names>S.</given-names></name><name><surname>Adriaenssens</surname><given-names>E.</given-names></name><name><surname>Ricort</surname><given-names>J.M.</given-names></name><name><surname>Bernard</surname><given-names>D.</given-names></name><name><surname>Boilly</surname><given-names>B.</given-names></name><name><surname>Le Bourhis</surname><given-names>X.</given-names></name></person-group><article-title>Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling</article-title><source>Exp. Cell Res.</source><year>2002</year><volume>275</volume><fpage>31</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1006/excr.2002.5490</pub-id><pub-id pub-id-type="pmid">11925103</pub-id></element-citation></ref></ref-list></back></article>